Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
BMC Cancer|September 7, 2012
Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tractAugust Zabernigg, Johannes M Giesinger, Georg Pall, et al.
Wiener Klinische Wochenschrift|December 25, 2007
[Small cell lung cancer]Stefan Hoschek, Ursula Hoschek-Risslegger, Michael Fiegl, et al.
Wiener Medizinische Wochenschrift (1946)|December 25, 2007
[Updated strategies in Small Cell Lung Cancer post ASCO 2007]Stefan Hoschek, Ursula Hoschek-Risslegger, Michael Fiegl, et al.
Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.
BMC Cancer|August 25, 2017
Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world settingMonika Sztankay, Johannes Maria Giesinger, August Zabernigg, et al.
Wiener Klinische Wochenschrift|September 16, 2021
Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter studySabine Geiger-Gritsch, Horst Olschewski, Florian Kocher, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Anticancer Research|February 28, 2023
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck CancerSandro M Wagner, Teresa Magnes, Thomas Melchardt, et al.
Plos One|May 29, 2015
Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study)Wolfgang Hilbe, Georg Pall, Florian Kocher, et al.
Oncoimmunology|December 21, 2023
Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLCStefan Koeck, Arno Amann, Johan Kern, et al.
Pageof 3